期刊文献+

甘草酸二铵肠溶胶囊治疗甲巯咪唑所致的肝功能异常的疗效观察 被引量:1

Clinical observation of the effect of diammonium glycyrrhizinate enteric-coated capsule on medicamentous liver lesion induced by methimazole
原文传递
导出
摘要 目的:评价甘草酸二铵肠溶胶囊治疗甲巯咪唑所致的肝功能异常的临床疗效。方法:因甲巯咪唑所致肝功能异常的患者分为治疗组29例及对照组28例,治疗组给予甘草酸二铵肠溶胶囊口服,对照组组予护肝片口服,观察比较2周后2组患者治疗肝损害的疗效。结果:2组治疗后丙氨酸氨基转移酶(ALT)、碱性磷酸酶(ALP)及总胆红素较治疗前均明显下降(P<0.05),2组之间差异无显著性(P>0.05)。治疗组总有效率(89.66%)明显高于对照组(75.00%)(P<0.05)。结论:甘草酸二铵肠溶胶囊治疗甲巯咪唑所致的肝功能异常有较好的治疗效果。 OIMECYIVE To evaluate the clinical efficacy of diammonium glycyrrhizinate enteric-coated capsule on medica- mentous liver lesion induced by methimazole. METHODS Fifty-seven patients were randomly divided into two groups: treat- ment gronp(n = 29) and control group(n = 28). Patients in treatment group took diammonium glycyrrhizinate enteric-coated capsules, while patients in control group took tablets of liver-protectiorL RESULTS After the treatment for 2 weeks, the levels of alanine aminotransferase(ALT), alkaline phosphatase(ALP), and total bilirubin (TBIL) were significantly decreased than those before treatment (P〈0. 05), but there was no significant difference between two groups (P〉0. 05). The total effective rate in the treatment group (89. 66%) was higher than that in the control group (75.00%) (P〈0. 05). CONCLUSION Diam- monium glycyrrhizinate capsule is more effective in the treatment of the hepato-toxicity caused by methimazole in patients with hyperthyroidism.
机构地区 绍兴市人民医院
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第11期922-924,共3页 Chinese Journal of Hospital Pharmacy
关键词 甘草酸二铵肠溶胶囊 甲巯咪唑 药物治疗 肝功能异常 diammonium glycyrrhizinate enteric-coated capsule~ methimazole drug treatment liver lesion,
  • 相关文献

参考文献5

二级参考文献23

  • 1连小兰,白耀,戴为信,金自孟,曾正陪,郭芝生.丙硫氧嘧啶导致症状性肝损伤的临床特征及相关因素分析[J].中华内科杂志,2004,43(6):442-446. 被引量:22
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 3Younossi ZM. Review article:current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis [ J ]. Aliment Pharmacol Ther,2008,28 : 2 - 12.
  • 4Lieber CS, Leo MA, Cao Q, et al. Silymarin retards the progression of alcohol-induced hepatic: fibrosis in baboons[J]. Clin Gastroenterol,2003,37 ( 3 ) :36 - 39.
  • 5Siebler J, Gallc P. Treatment of nonalcoholic fatty liver[ J]. Would J Gastroenteroi ,2006,12:2161 - 2167.
  • 6Gulbahar O, Karasu ZA, Ersoz G, et al. Treatment of non-alcoholic steatohepatitis with N-acetylcysteine[J]. Gastroenterology, 2000, 118 : 1444 - 1447.
  • 7Portincasa P. Current pharmacological treatment of nonalcoholic fatty liver. [ J ]. Cochrane Database Syst Rev, 2007,24 ( 1 ) : CD0004996.
  • 8Lirussi F, Mastropasqua E, Orando S, et al. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis[ J ]. Cochrane Database Syst Rev,2007,24, ( 1 ) :CD005165.
  • 9Huang M J,Li KL,Wei JS,et al.Sequential liver and bone biochemical changes in hyperthyroidism:prospective controlled follow-up study[J].Am J Gastroenterol,1994,89 (7):1071-1074.
  • 10Aydemir S,Bayraktaroglu T,Demircan N,et al.Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests[J].IntJ Clin Pract,2005,59 (11):1304-1308.

共引文献56

同被引文献20

  • 1Thomas SK,Sheffield JS,Roberts SW.Thionamide-induced neutropenia and ecthyma in a pregnant patient with hyperthyroidism[J].Obstet Gynecol,2013,122(2):490-492.
  • 2Minamitani K,Oikawa J,Wataki K,et al.A Report of three girls with antithyroid drug-induced agranulocytosis;retrospective analysis of 18 cases aged 15 years or younger reported between 1995 and 2009[J].Clin Pediatr Endocrinol,2011,20(2):39-46.
  • 3Yang J,Zhong J,Zhou LZ,et al.Sudden onset agranulocytosis and hepatotoxicity after taking methimazole[J].Intern M ed,2012,51(16):2189-2192.
  • 4Mutharasan P,Oatis W,Kwaan H,et al.Delayed anithyroid drug-induced agranulocytosis[J].Endocr Pract,2012,18(4):69-72.
  • 5Watanabe N,Narimatsu H,Noh JY,et al.Antithyroid drug-induced hematopoietic damage:a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves'disease[J].J Clin Endocrinol M etab,2012,97(1):49-53.
  • 6Casallo Blanco S,Valero MA,Marcos Sanchez F,et al.Methimazole and propylthiouracil induced acute toxic hepatitis[J].Gastroenterol Hepatol,2007,30(5):268-270.
  • 7Zhang M,Zhou H,He R,et al.Steroids for the treatment of methimazole-induced severe cholestatic jaundice in a 74-yearold woman with type 2 diabetes[J].Endocrine,2010,37(2):241-243.
  • 8Gallelli L,Staltari O,Palleria C,et al.Hepatotoxicity induced by methimazole in a previously healthy patient[J].Curr Drug Saf,2009,4(3):204-206.
  • 9Seo JY,Byun HJ,Cho KH,et al.Methimazole-induced bullous systemic lupus erythematosus:a case report[J].J Korean M ed Sci,2012,27(7):818-821.
  • 10Nihei H,Tada H,Naruse Y,et al.Polyarthritis caused by methimazole in two Japanese patients with graves'disease[J].J Clin Res Pediatr Endocrinol,2013,5(4):270-272.

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部